Lactobacillus reuteri

N/A

Report date: 2026/02/13 20:01:31

Base Information

Drug NameLactobacillus reuteri
Drug Alias Name罗伊氏乳杆菌Lactobacillus reuteri DSM 17938Lactobacillus reuteri ATCC 55730Lactobacillus reuteri ProtectisNEC therapy - BioGaia +[9] 
ClassificationNatural product/Extract > Microbial extractBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsGastrointestinal microbiome modulators
TargetsNot applicable
Therapy Area/IndicationsAlopeciaEnterocolitis, NecrotizingGastrointestinal Diseases
Global Approved IndicationsGastrointestinal Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2009/04/30
Country/TerritoryBulgariaUnited StatesPoland +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBiogaia Ab
China Registration ClassN/A

Develop Information

Active CompaniesBiogaia AbShenzhen People'S HospitalInfant Bacterial Therapeutics Ab
Inactive CompaniesN/A
Active IndicationsAlopeciaEnterocolitis, NecrotizingGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeA07FA01
Related LinksWikipediaDrugBankKEGG